| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
29,474 |
23,829 |
$2.21M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,038 |
21,598 |
$1.78M |
| 36415 |
Collection of venous blood by venipuncture |
60,528 |
39,863 |
$1.10M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
14,024 |
11,251 |
$753K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,642 |
7,590 |
$410K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,687 |
3,054 |
$371K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,811 |
1,533 |
$208K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,234 |
2,770 |
$202K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
724 |
640 |
$192K |
| 59025 |
Fetal non-stress test |
2,409 |
1,861 |
$187K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,658 |
5,155 |
$165K |
| 80053 |
Comprehensive metabolic panel |
37,040 |
27,070 |
$157K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,870 |
782 |
$146K |
| 86901 |
|
3,589 |
2,941 |
$141K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,434 |
2,863 |
$132K |
| 84484 |
|
10,505 |
6,324 |
$95K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,776 |
1,356 |
$91K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,298 |
1,742 |
$89K |
| 83690 |
|
7,210 |
5,867 |
$85K |
| 87205 |
|
8,553 |
7,164 |
$84K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,028 |
5,991 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,355 |
1,738 |
$79K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
859 |
756 |
$69K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,305 |
8,297 |
$61K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,439 |
2,879 |
$58K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
149 |
146 |
$56K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,387 |
4,304 |
$56K |
| 97161 |
|
911 |
778 |
$54K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,335 |
1,612 |
$53K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,765 |
6,883 |
$52K |
| 81025 |
|
10,711 |
8,775 |
$48K |
| 81001 |
|
24,127 |
19,468 |
$42K |
| 82962 |
|
5,096 |
2,385 |
$33K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,685 |
1,475 |
$31K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
652 |
533 |
$31K |
| G0378 |
Hospital observation service, per hour |
3,476 |
2,156 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,810 |
1,372 |
$29K |
| 87400 |
|
1,730 |
1,496 |
$28K |
| 87070 |
|
617 |
508 |
$26K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,446 |
1,197 |
$25K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
998 |
851 |
$23K |
| 76801 |
|
2,798 |
2,175 |
$23K |
| 83605 |
|
1,680 |
1,254 |
$23K |
| 74174 |
|
152 |
136 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
3,007 |
2,551 |
$21K |
| 73610 |
|
989 |
809 |
$20K |
| 80047 |
|
3,919 |
3,154 |
$20K |
| 76830 |
Ultrasound, transvaginal |
1,533 |
1,334 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,091 |
1,248 |
$20K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,569 |
1,174 |
$20K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,606 |
1,291 |
$19K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
16,653 |
13,598 |
$18K |
| 87186 |
|
2,142 |
1,738 |
$18K |
| 86900 |
|
3,603 |
2,949 |
$18K |
| 73130 |
|
1,040 |
859 |
$16K |
| 73562 |
|
1,530 |
1,223 |
$16K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
401 |
362 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
10,142 |
8,089 |
$16K |
| 84702 |
|
5,396 |
4,003 |
$14K |
| 83735 |
|
4,585 |
3,249 |
$14K |
| 73030 |
|
1,037 |
851 |
$13K |
| 73630 |
|
1,135 |
975 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42,191 |
31,672 |
$13K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,366 |
3,082 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,646 |
2,041 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,036 |
821 |
$10K |
| 87631 |
|
1,565 |
1,387 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,413 |
8,065 |
$10K |
| 87430 |
|
950 |
836 |
$10K |
| 93971 |
|
888 |
729 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
3,150 |
2,526 |
$9K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,685 |
2,897 |
$9K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,514 |
4,736 |
$9K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
492 |
434 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,766 |
3,973 |
$8K |
| 97597 |
|
139 |
68 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,498 |
2,686 |
$8K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
14,661 |
7,751 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,370 |
6,486 |
$8K |
| 10060 |
|
173 |
145 |
$8K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
14 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
283 |
247 |
$7K |
| 97162 |
|
146 |
123 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
538 |
441 |
$7K |
| 99218 |
|
1,855 |
1,623 |
$7K |
| 83615 |
|
1,377 |
1,040 |
$6K |
| 70491 |
|
15 |
12 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,594 |
7,550 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,680 |
2,135 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,976 |
2,017 |
$5K |
| 82746 |
|
1,315 |
1,009 |
$5K |
| 70486 |
|
594 |
487 |
$5K |
| 82550 |
|
2,753 |
2,049 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
28 |
12 |
$5K |
| 93970 |
|
402 |
332 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,291 |
1,875 |
$5K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$5K |
| 85027 |
|
8,218 |
5,770 |
$4K |
| 85610 |
|
7,184 |
4,383 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,064 |
6,021 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
110 |
84 |
$4K |
| 83880 |
|
2,145 |
1,665 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,667 |
4,359 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,463 |
2,005 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
975 |
727 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,680 |
1,456 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,048 |
922 |
$3K |
| 73110 |
|
337 |
278 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,747 |
2,246 |
$3K |
| 76818 |
|
62 |
52 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,205 |
2,465 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,498 |
1,785 |
$2K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
354 |
259 |
$2K |
| 82607 |
|
2,988 |
2,278 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
506 |
451 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,882 |
3,205 |
$2K |
| 80061 |
Lipid panel |
5,071 |
3,863 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,253 |
5,717 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
100 |
81 |
$2K |
| 85014 |
|
3,990 |
3,172 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,453 |
2,342 |
$2K |
| 86592 |
|
838 |
719 |
$2K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
309 |
227 |
$2K |
| 72100 |
|
216 |
187 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,609 |
3,511 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
107 |
57 |
$1K |
| 73502 |
|
149 |
110 |
$1K |
| 87210 |
|
797 |
650 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,758 |
2,079 |
$1K |
| 80076 |
|
377 |
305 |
$1K |
| 01999 |
|
292 |
271 |
$1K |
| 76641 |
|
23 |
14 |
$935.37 |
| 74018 |
|
57 |
44 |
$907.97 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
956 |
786 |
$899.04 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
34 |
26 |
$887.21 |
| 85730 |
|
2,204 |
1,762 |
$880.17 |
| 87077 |
|
1,812 |
1,446 |
$871.45 |
| 90715 |
|
993 |
828 |
$834.65 |
| 97116 |
|
146 |
81 |
$827.53 |
| 80164 |
|
414 |
321 |
$812.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,048 |
2,337 |
$768.17 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
58 |
46 |
$740.56 |
| 82140 |
|
273 |
214 |
$740.13 |
| J2060 |
Injection, lorazepam, 2 mg |
1,735 |
1,270 |
$715.24 |
| 84439 |
|
2,061 |
1,598 |
$697.23 |
| 80074 |
|
62 |
52 |
$681.91 |
| 85379 |
|
2,030 |
1,710 |
$676.51 |
| 96376 |
|
1,162 |
820 |
$647.42 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
51 |
42 |
$561.88 |
| 82570 |
|
1,901 |
1,455 |
$541.63 |
| 86850 |
|
2,246 |
1,859 |
$522.19 |
| 87806 |
|
14 |
13 |
$480.15 |
| 99499 |
|
16 |
16 |
$452.39 |
| 85652 |
|
1,395 |
1,012 |
$418.13 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,053 |
828 |
$404.18 |
| 87081 |
|
439 |
383 |
$396.44 |
| 76642 |
|
16 |
12 |
$374.76 |
| 72131 |
|
54 |
39 |
$359.96 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
124 |
39 |
$333.70 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
507 |
419 |
$324.48 |
| 72110 |
|
28 |
24 |
$324.18 |
| 12002 |
|
13 |
12 |
$307.64 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
693 |
594 |
$266.07 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
243 |
199 |
$258.64 |
| 86141 |
|
1,313 |
977 |
$255.02 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,428 |
693 |
$254.11 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
13 |
$229.78 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
459 |
330 |
$216.90 |
| 94760 |
|
1,230 |
616 |
$207.02 |
| 82150 |
|
281 |
227 |
$193.74 |
| 82330 |
|
304 |
247 |
$180.80 |
| J1953 |
Injection, levetiracetam, 10 mg |
220 |
162 |
$169.95 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
455 |
331 |
$168.41 |
| 73590 |
|
32 |
27 |
$153.33 |
| 84156 |
|
1,370 |
1,059 |
$139.05 |
| 84703 |
|
398 |
345 |
$130.04 |
| 82728 |
|
634 |
481 |
$116.54 |
| 81003 |
|
2,067 |
1,698 |
$115.11 |
| 84550 |
|
1,475 |
1,117 |
$113.87 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
829 |
718 |
$101.36 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
317 |
257 |
$100.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
165 |
148 |
$91.45 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
70 |
45 |
$56.14 |
| 80177 |
|
143 |
114 |
$55.94 |
| 76857 |
|
17 |
13 |
$44.30 |
| 86706 |
|
48 |
40 |
$41.60 |
| 84100 |
|
286 |
172 |
$34.78 |
| 83540 |
|
825 |
667 |
$33.05 |
| 88342 |
|
181 |
174 |
$31.30 |
| 82248 |
|
157 |
133 |
$30.88 |
| 82043 |
|
141 |
93 |
$26.84 |
| 82803 |
|
14 |
12 |
$25.19 |
| 84132 |
|
252 |
207 |
$25.19 |
| 84295 |
|
244 |
203 |
$25.19 |
| 82947 |
|
265 |
221 |
$25.19 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
146 |
129 |
$21.66 |
| 87340 |
|
115 |
105 |
$20.23 |
| 83550 |
|
125 |
94 |
$19.30 |
| 84145 |
|
77 |
53 |
$16.28 |
| 94644 |
|
26 |
25 |
$13.46 |
| 84480 |
|
101 |
81 |
$9.07 |
| 84630 |
|
21 |
13 |
$7.84 |
| 72040 |
|
19 |
13 |
$7.47 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
43 |
37 |
$3.36 |
| 82553 |
|
59 |
39 |
$0.86 |
| 85018 |
|
94 |
65 |
$0.43 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
459 |
431 |
$0.00 |
| 82435 |
|
225 |
188 |
$0.00 |
| 84134 |
|
23 |
12 |
$0.00 |
| 86803 |
|
29 |
26 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
19 |
15 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
186 |
122 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
37 |
37 |
$0.00 |
| 87040 |
|
69 |
42 |
$0.00 |
| 87581 |
|
33 |
26 |
$0.00 |
| 87486 |
|
33 |
26 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
12 |
12 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
34 |
33 |
$0.00 |
| 87147 |
|
17 |
13 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
25 |
13 |
$0.00 |
| 73080 |
|
29 |
26 |
$0.00 |
| 84520 |
|
220 |
184 |
$0.00 |
| 82565 |
|
241 |
198 |
$0.00 |
| 00840 |
|
27 |
24 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
15 |
12 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
20 |
18 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
33 |
26 |
$0.00 |
| 00731 |
|
13 |
13 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
32 |
14 |
$0.00 |
| Q0114 |
Fern test |
14 |
12 |
$0.00 |